EATG » Access

Access

“East Europe & Central Asia: Let’s not lose track!” – EECA communities position on HIV situation in the region

As leaders of the HIV response gather in New York on June 8-10 for the 2016 High-Level Meeting on HIV/AIDS, civil society networks of the EECA region prepared the “East…

NHS England confuses arse and elbow: block to PrEP ignores UK HIV crisis and will send PEP services into chaos

In an act of breathtaking stupidity, NHS England and its network of commissioning committees and advisory structures are scrambling to find bureaucratic loopholes to further block access to to the most…

Cost is biggest barrier to PrEP in Europe, ECDC declares

Study finds significant PrEP use in gay men throughout Europe: France starts its programme European demonstration projects and opinions on PrEP A meeting a month ago at the European Centre…

UNAIDS: Intellectual property and access to health technologies

The document provides a review of key issues related to intellectual property policies and their potential impact on access to HIV and other medicines. It is intended as an introduction…

France to provide universal access to hepatitis C treatment

France will provide access to hepatitis C treatment with direct-acting antivirals to everyone diagnosed with hepatitis C from September 2016, and will begin to provide treatment to everyone with stage…

UNAIDS announces 2 million more people living with HIV on treatment in 2015, bringing new total to 17 million

New report from UNAIDS shows that the number of people accessing antiretroviral medicines has more than doubled since 2010 GENEVA/NAIROBI, 31 May 2016—An estimated 17 million people were accessing life-saving…

Burden of pricey hepatitis C drugs heaviest in Eastern Europe

May 31, 2016 - New hepatitis C drugs that can cure the liver-destroying disease are revolutionizing treatment but their high price is a huge burden in some countries, particularly in…

NHS England: Further update on commissioning and provision of PrEP for HIV prevention

31 May 2016 - PrEP is a way of using anti-retroviral drugs – usually used for treating people with diagnosed HIV-  to stop viral transmission. Evidence of effectiveness is strongest…

New UN treatment targets for HIV/AIDS would be ‘expensive but worth every penny’

A new study finds that implementing the United Nations targets for HIV testing and treatment would be an expensive but ultimately very cost-effective way to increase survival, reduce the number…

Drug pricing, generics figure into WHO strategies on HIV, hepatitis

May 28, 2016 - As the 69th World Health Assembly draws to a close, member states are in the process of approving a series of draft global health sector strategies…